Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer
A new Jama Oncology study shows gastric acid suppressants (proton pump inhibitors) negatively affect capecitabine efficacy, an oral cytotoxic chemotherapeutic commonly used... Read More
Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer
New research shows the number of retrieved lymph nodes during gastric cancer treatment may affect the prognosis and the stage migration in... Read More
Daiichi Sankyo Presents Late-Breaking Phase 1 Data for Novel Investigational HER2-Targeting Antibody Drug Conjugate DS-8201a in T-DM1 Pre-Treated Breast Cancer at the ESMO 2016 Congress
Preliminary trials for a new antibody drug shows patients tolerated the treatment well with a 90% disease control rate for gastric cancer... Read More
Cancer Death Rates Vary Among Asian Ethnic Groups, Study Finds
A study of cancer mortality rates and trends among Asian Americans has revealed that specific ethnic groups face higher rates of some cancer types.
New Drugs, Immuno-Oncology Advances Gastric Cancer Treatment Paradigm
Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, MD.
Immunotherapy on the Horizon in Gastric Cancer
While the utilization of immunotherapy in gastric cancer may not be as clear cut as it is in melanoma or lung cancer,... Read More
Proper Classification, Multidisciplinary Approach Key in Gastric Cancer
Not all gastroesophageal junction (GEJ) cancers should be treated the same, according to Richard J. Bold, MD, chief, Surgical Oncology, professor, UC... Read More
Apatinib Shows Promising Survival Advantage in Advanced Gastric Cancer
Apatinib demonstrated an improvement in overall survival (OS) by 1.8 months and an acceptable toxicity profile compared to placebo as treatment for... Read More
Health IT Essential for the Success of Cancer Moonshot
Gregory C. Simon, executive director, White House Cancer Task Force, spoke at the National Comprehensive Cancer Network Policy Summit in Washington, DC.... Read More
A Novel, Targeted Drug Yields Promising Results in Stomach and Esophageal Cancer at ASCO
An antibody that binds a protein present in a subset of gastric tumors has been shown to extend survival in patients with... Read More